All data are based on the daily closing price as of November 5, 2024
s

Shinpoong Pharm

019170.KO
8.67 USD
-0.05
-0.57%

Overview

Last close
8.67 usd
Market cap
426.96M usd
52 week high
15.74 usd
52 week low
7.67 usd
Target price
4.19 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.8178
Price/Book Value
2.306
Enterprise Value
436.45M usd
EV/Revenue
2.8805
EV/EBITDA
-52.8402

Key financials

Revenue TTM
151.52M usd
Gross Profit TTM
56.16M usd
EBITDA TTM
-13.61M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
340.83B usd
Net debt
N/A usd

About

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.
  • Symbol
    019170.KO
  • Exchange
    KO
  • Isin
    KR7019170000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://shinpoong.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top